Sowell Financial Services LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$472.8 - $558.54 $177,772 - $210,011	-376 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $56,287 - $69,073	-126 Reduced 25.1%	376 $188,000
Q4 2020 Jan 13, 2021	SELL	$478.3 - $607.98 $66,962 - $85,117	-140 Reduced 21.81%	502 $243,000
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $470,664 - $568,693	-864 Reduced 57.37%	642 $359,000
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $512,559 - $669,032	1,039 Added 222.48%	1,506 $939,000
Q1 2020 May 12, 2020	SELL	$336.18 - $494.43 $20,170 - $29,665	-60 Reduced 11.39%	467 $228,000
Q4 2019 Feb 07, 2020	BUY	$274.13 - $376.51 $49,069 - $67,395	179 Added 51.44%	527 $197,000
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $95,164 - $110,799	348 New	348 $97,000

1,485

84.8M

1.51M

1.48M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.